Possible roles of tumor necrosis factor-α and angiotensin II type 1 receptor on high glucose-induced damage in renal proximal tubular cells

References

• Mather A, Pollock C. Glucose handling by the kidney. Kidney Int Suppl. 2011;(120):S1–S6
   Web of Science ®Google Scholar
• Vallon V, Platt KA, Cunard R, et al. SGLT2 mediates glucose reabsorption in the early proximal tubule. J Am Soc Nephrol. 2011;22(1):104–112
   PubMed Web of Science ®Google Scholar
• Dzau VJ, Paul M, Nakamura N, Pratt RE, Ingelfinger JR. Role of molecular biology in hypertension research. State of the art lecture. Hypertension. 1989;13(6 Pt 2):731–740
   PubMedGoogle Scholar
• Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest. 1990;85(2):417–423
   PubMedGoogle Scholar
• Wolf G, Neilson EG. Effects of angiotensin II on proximal tubular cells stably transfected with the c-mas oncogene. Am J Physiol. 1992;263(5 Pt 2):F931–F938
   Google Scholar
• Loghman-Adham M, Rohrwasser A, Helin C, et al. A conditionally immortalized cell line from murine proximal tubule. Kidney Int. 1997;52(1):229–239
   PubMedGoogle Scholar
• Burns KD, Inagami T, Harris RC. Cloning of a rabbit kidney cortex AT1 angiotensin II receptor that is present in proximal tubule epithelium. Am J Physiol. 1993;264(4 Pt 2):F645–F654
   Google Scholar
• Lai KN, Leung JC, Lai KB, To WY, Yeung VT, Lai FM. Gene expression of the renin-angiotensin system in human kidney. J Hypertens. 1998;16(1):91–102
   PubMedGoogle Scholar
• Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int. 2000;57(2):601–606
   PubMed Web of Science ®Google Scholar
• Zimpelmann J, Kumar D, Levine DZ, et al. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int. 2000;58(6):2320–2330
   PubMed Web of Science ®Google Scholar
• Takao T, Horino T, Kagawa T, et al. Possible involvement of intracellular angiotensin II receptor in high-glucose-induced damage in renal proximal tubular cells. J Nephrol. 2011;24(2):218–224
   PubMedGoogle Scholar
• Zhang SL, To C, Chen X, et al. Essential role(s) of the intrarenal renin-angiotensin system in transforming growth factor-beta1 gene expression and induction of hypertrophy of rat kidney proximal tubular cells in high glucose. J Am Soc Nephrol. 2002;13(2):302–312
   PubMedGoogle Scholar
• Moresco RN, Sangoi MB, De Carvalho JA, Tatsch E, Bochi GV. Diabetic nephropathy: Traditional to proteomic markers. Clin Chim Acta. 2013;421:17–30
   PubMed Web of Science ®Google Scholar
• Ortiz A, Egido J. Is there a role for specific anti-TNF strategies in glomerular diseases? Nephrol Dial Transpl. 1995;10(3):309–311
   PubMed Web of Science ®Google Scholar
• Zhang B, Ramesh G, Norbury CC, Reeves WB. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. Kidney Int. 2007;72(1):37–44
   PubMedGoogle Scholar
• Kitada K, Nakano D, Hitomi H, et al. Aldosterone induces p21-regulated apoptosis via increased synthesis and secretion of tumour necrosis factor-alpha in human proximal tubular cells. Clin Exp Pharmacol Physiol. 2012;39(10):858–863
   PubMedGoogle Scholar
• Sachse A, Wolf G. Angiotensin II-induced reactive oxygen species and the kidney. J Am Soc Nephrol. 2007;18(9):2439–2446
   PubMedGoogle Scholar
• Hennet T, Richter C, Peterhans E. Tumour necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells. Biochem J. 1993;289(Pt 2):587–592
   PubMedGoogle Scholar
• Sonta T, Inoguchi T, Matsumoto S, et al. In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker. Biochem Biophys Res Commun. 2005;330(2):415–422
   PubMedGoogle Scholar
• Kagawa T, Takao T, Horino T, et al. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells. Nephrology (Carlton). 2008;13(4):309–315
   PubMedGoogle Scholar
• Takao T, Horino T, Kagawa T, et al. Effects of angiotensin II type 1 receptor blocker on albumin-induced cell damage in human renal proximal tubular epithelial cells. Am J Nephrol. 2009;29(2):102–108
   PubMedGoogle Scholar
• Zhou L, Xue H, Yuan P, et al. Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells. Clin Exp Pharmacol Physiol. 2010;37(9):e152–e157
   Google Scholar
• Speeckaert MM, Speeckaert R, Laute M, Vanholder R, Delanghe JR. Tumor necrosis factor receptors: Biology and therapeutic potential in kidney diseases. Am J Nephrol. 2012;36(3):261–270
   PubMed Web of Science ®Google Scholar
• Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology. 2002;143(8):2975–2985
   PubMed Web of Science ®Google Scholar
• Yang CM, Lee IT, Hsu RC, Chi PL, Hsiao LD. NADPH oxidase/ROS-dependent PYK2 activation is involved in TNF-alpha-induced matrix metalloproteinase-9 expression in rat heart-derived H9c2 cells. Toxicol Appl Pharmacol. 2013;272(2):431–442
   PubMedGoogle Scholar
• Zhang C, Hein TW, Wang W, Ren Y, Shipley RD, Kuo L. Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles. J Mol Cell Cardiol. 2006;40(2):247–257
   PubMed Web of Science ®Google Scholar
• Arenas IA, Xu Y, Lopez-Jaramillo P, Davidge ST. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. Am J Physiol Cell Physiol. 2004;286(4):C779–C784
   Google Scholar
• Sasamura H, Nakazato Y, Hayashida T, Kitamura Y, Hayashi M, Saruta T. Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension. 1997;30(1 Pt 1):35–41
   PubMed Web of Science ®Google Scholar
• Shi P, Diez-Freire C, Jun JY, et al. Brain microglial cytokines in neurogenic hypertension. Hypertension. 2010;56(2):297–303
   PubMedGoogle Scholar
• Lu Y, Chen J, Yin X, Zhao H. Angiotensin II receptor 1 involved in the central pressor response induced by interleukin-1 beta in the paraventricular nucleus. Neurol Res. 2009;31(4):420–424
   PubMed Web of Science ®Google Scholar
• Li Z, Chen XD, Ni SK, Li JW, Lin MS. Olmesartan inhibits the expression of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha and improves vascular remodeling after vascular injury in mouse. Chin J Traumatol. 2004;7(1):56–61
   PubMedGoogle Scholar
• Araujo AA, Lopes de Souza G, Souza TO, et al. Olmesartan decreases IL-1beta and TNF-alpha levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. Naunyn Schmiedeberg's Arch Pharmacol. 2013;386(10):875–884
   Google Scholar
• Kataoka H, Murakami R, Numaguchi Y, Okumura K, Murohara T. Angiotensin II type 1 receptor blockers prevent tumor necrosis factor-alpha-mediated endothelial nitric oxide synthase reduction and superoxide production in human umbilical vein endothelial cells. Eur J Pharmacol. 2010;636(1–3):36–41
   PubMedGoogle Scholar